DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Esmolol Hydrochloride Double Strength In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. There are four patents protecting this drug.
This drug has forty-five patent family members in twenty-five countries.
The generic ingredient in ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER is esmolol hydrochloride. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the esmolol hydrochloride profile page.
A generic version of esmolol hydrochloride double strength in plastic container was approved as esmolol hydrochloride by WEST-WARD PHARMS INT on August 10th, 2004.
Summary for esmolol hydrochloride double strength in plastic container
|Suppliers / Packagers:||1|
|Formulation / Manufacturing:||see details|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for esmolol hydrochloride double strength in plastic container|
|DailyMed Link:||esmolol hydrochloride double strength in plastic container at DailyMed|
Recent Clinical Trials for esmolol hydrochloride double strength in plastic container
Identify potential brand extensions & 505(b)(2) entrants
|Tianjin Nankai Hospital||N/A|
|CMC Ambroise Paré||Phase 3|
|National Cancer Institute, Egypt||Early Phase 1|
|Country||Patent Number||Estimated Expiration|
|South Korea||100889090||Start Trial|
|Russian Federation||2286774||Start Trial|
|Czech Republic||20023825||Start Trial|
|>Country||>Patent Number||>Estimated Expiration|